Bringing together deep bioscience and AI to help patients worldwide

For a new compound to make it from initial discovery through development, testing and clinical trials to finally earn regulatory approval can take a decade or more. Nine out of 10 promising drug candidates fail somewhere along the way. As a result, on average, it costs life sciences companies $2.6 billion to introduce a single new prescription drug. This is much more than just a challenge for life sciences companies. Streamlining drug development is an urgent issue for human health more broadly.